A New Genetic Link: Shared Loci Connect Heart Failure Risk Factors and Psychiatric Disorders
A recent genetic correlation analysis published in Alzheimer’s & Dementia has uncovered significant shared heritability between Alzheimer’s disease (AD) and major psychiatric disorders, including depression and anxiety. The study, leveraging genome-wide association data from nearly half a million individuals for AD and over a million for depression, identified specific genetic loci implicated in both conditions. Key findings pinpoint a missense variant in the TMEM106B gene, associated with AD, depression, and anxiety, and regulatory variants in the ACE gene, shared between AD and schizophrenia. The ACE gene, widely studied in cardiovascular disease for its role in blood pressure regulation and cardiac remodeling, is a critical component of the renin-angiotensin system targeted by ACE inhibitor therapy for hypertension and heart failure. This research provides a novel molecular framework for understanding the comorbidity of neuropsychiatric symptoms in neurodegenerative and potentially cardiometabolic diseases, suggesting common underlying inflammatory and vascular pathways.
Study Significance: For cardiology professionals, this finding underscores the importance of the ACE pathway beyond traditional cardiovascular risk prediction and management of hypertension. It suggests that genetic variants in cardiometabolic genes like ACE may have pleiotropic effects, influencing susceptibility to both neuropsychiatric and vascular conditions. This insight could refine risk stratification models, encouraging a more integrated approach to patient care that considers shared genetic vulnerabilities for heart failure, cognitive decline, and mood disorders, potentially informing future therapeutic strategies that target common inflammatory or endothelial dysfunction pathways.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
